Finland· FI-REL-REL6318
Theo-Dur
A theophylline product, registered in Finland by Aktiebolaget Draco. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Theophylline is registered in 12 of 19 countries.
Countries holding a registration under ATC R03DA04 (theophylline), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Theophylline · ATC R03DA04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of theophylline costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Theophylline · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- US United States$0.71 (acquisition cost)
The record
At a glance
Fimea (Finland)- Manufacturer
- Aktiebolaget Draco
- Country
- Finland (FI)
- ATC code
- R03DA04
- ATC class
- Theophylline
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
438 interactions on record for theophylline.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Theophylline · interactions on record
438 records
- 34 severe
- 222 moderate
- 45 minor
- 132 info
Most severe, free to view
- MexiletineC01BB02severe
- RiociguatC02KX05severe
- PindololC07AA03severe
- PropranololC07AA05severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03DA04
Theophylline, as other registers publish it.
- CanadaAA-THEO LAAA PHARMA INC
- CanadaAA-THEO LAAA PHARMA INC
- CanadaAA-THEO LAAA PHARMA INC
- CzechiaAFONILUM SRMylan IRE Healthcare Limited, Dublin
- CzechiaAFONILUM SRMylan IRE Healthcare Limited, Dublin
- CzechiaAFONILUM SRVIATRIS HEALTHCARE LIMITED, Dublin
- CzechiaAFONILUM SRMylan IRE Healthcare Limited, Dublin
- CzechiaAFONILUM SRVIATRIS HEALTHCARE LIMITED, Dublin
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3115255-cdf9-41a2-99de-e0c340b64920 GET /v1/drugs/b3115255-cdf9-41a2-99de-e0c340b64920?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "injektioneste",
"route": null,
"ddd_unit": "g",
"strength": "20 mg/ml",
"atc_label": "teofylliini",
"ma_number": "9455",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL6318",
"authorised_at": "1987-04-01"
}See everything about theophylline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.